Purpose
to test a new vaccine technology that modulates a host cytokine response to HIV vaccines. If successful, this technology may also enhance T-cell mediated immunity to other vaccine antigens, such as Tuberculosis.
Grantee
Division
Global Health
Date
APRIL 2010
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
12
Grantee location
Acton, Australia
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.